Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

book cover photo
StatPearls [Internet]
NCBI Bookshelf
Full text links

Actions

Share

Book

Nitroglycerin

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Nitroglycerin

Kyle H. Kim et al.
Free Books & Documents

Excerpt

Nitroglycerin is a vasodilatory drug used primarily to provide relief from anginal chest pain. It is currently FDA approved for the acute relief of an attack or acute prophylaxis of angina pectoris secondary to coronary artery disease. Off-label, non-FDA-approved uses include treatment for hypertensive urgency/emergency, coronary artery spasm, angina secondary to cocaine use, congestive heart failure (CHF), and chronic anal fissures. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, monitoring, and toxicity of nitroglycerin, so providers can direct patient therapy successfully in instances where nitroglycerin benefits patient care.

Copyright © 2025, StatPearls Publishing LLC.

PubMed Disclaimer

Conflict of interest statement

Disclosure:Kyle Kim declares no relevant financial relationships with ineligible companies.

Disclosure:Connor Kerndt declares no relevant financial relationships with ineligible companies.

Disclosure:Ghufran Adnan declares no relevant financial relationships with ineligible companies.

Disclosure:Derek Schaller declares no relevant financial relationships with ineligible companies.

Sections

Similar articles

  • Tennessee Controlled Substance Prescribing for Acute and Chronic Pain.
    Dydyk AM, Sizemore DC, Trachsel LA, Dulebohn SC, Porter BR.Dydyk AM, et al.2023 May 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 May 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:33620833Free Books & Documents.
  • West Virginia Opioid Prescribing for Chronic Pain While Avoiding Drug Diversion.
    Dydyk AM, Sizemore DC, Trachsel LA, Conermann T, Porter BR.Dydyk AM, et al.2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:33090753Free Books & Documents.
  • Kentucky KASPER and Controlled Substance Prescribing.
    Dydyk AM, Sizemore DC, Smock W, Dulebohn SC, Porter BR.Dydyk AM, et al.2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:33620803Free Books & Documents.
  • Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
    Salisbury L, Baraitser L.Salisbury L, et al.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5.PMID:36137063Free Books & Documents.Review.
  • FBN1-Related Marfan Syndrome.
    Dietz H.Dietz H.2001 Apr 18 [updated 2022 Feb 17]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.2001 Apr 18 [updated 2022 Feb 17]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.PMID:20301510Free Books & Documents.Review.
See all similar articles

References

    1. Parratt JR. Nitroglycerin--the first one hundred years: new facts about an old drug. J Pharm Pharmacol. 1979 Dec;31(12):801-9. - PubMed
    1. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3203-7. - PMC - PubMed
    1. Thadani U, Lipicky RJ. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug;8(4):611-23. - PubMed
    1. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981 Dec;64(6):1089-97. - PubMed
    1. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol. 2000 Sep;184(3):409-20. - PubMed

Publication types

Related information

LinkOut - more resources

Full text links
book cover photo
StatPearls [Internet]
NCBI Bookshelf
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp